Multiple Sclerosis Treatment Options: Disease‑Modifying and Symptomatic Therapies
There is no cure for MS, but a growing arsenal of treatments modifies disease course and manages symptoms.
Disease‑Modifying Therapies (DMTs)
- Injectables: Interferon beta‑1a/1b, glatiramer acetate.
- Oral: Fingolimod, dimethyl fumarate, teriflunomide, siponimod, cladribine, ozanimod, ponesimod.
- Infusion/Monoclonal antibodies: Natalizumab, ocrelizumab, ofatumumab, alemtuzumab, ublituximab.
- Emerging: BTK inhibitors (tolebrutinib), CAR‑T, remyelination agents.
Symptomatic Management
- Spasticity: Baclofen, tizanidine, botulinum toxin.
- Fatigue: Amantadine, modafinil, energy conservation.
- Neuropathic pain: Gabapentin, pregabalin, duloxetine.
- Bladder: Anticholinergics, beta‑3 agonists, botox, catheterization.
- Depression/anxiety: SSRIs, SNRIs, CBT.
Rehabilitation & Lifestyle
- Physical/occupational/speech therapy.
- Exercise (aerobic, resistance, balance).
- Vitamin D supplementation, smoking cessation, healthy diet.
- Complementary: yoga, mindfulness, acupuncture (adjunctive).
Treatment is highly individualized; shared decision‑making with an MS specialist is essential.
Multiple Sclerosis - Related Articles
- Shingles Vaccine & Multiple Sclerosis: Exploring a Potential Link
- How I Find Work-Life Balance with MS
- Research on Future Treatments for Multiple Sclerosis
- Using Crutches with Multiple Sclerosis: A Comprehensive Guide
- Multiple Sclerosis and Action Potentials: How Demyelination Disrupts Nerve Signaling
- Understanding Chemotherapy for Multiple Sclerosis (MS)
- Scleroderma: Causes, Risk Factors & Understanding the Disease
